Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fueling the Fire: Inflammatory Forms of Cell Death and Implications for Cancer Immunotherapy
Sheera R. Rosenbaum, Nicole A. Wilski, Andrew E. Aplin
Cancer Discovery (2021) Vol. 11, Iss. 2, pp. 266-281
Open Access | Times Cited: 131

Showing 1-25 of 131 citing articles:

Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy
Weitong Gao, Yuqin Wang, Yang Zhou, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 600
Pyroptosis, metabolism, and tumor immune microenvironment
Tiantian Du, Jie Gao, Peilong Li, et al.
Clinical and Translational Medicine (2021) Vol. 11, Iss. 8
Open Access | Times Cited: 223
Ferroptosis, necroptosis, and pyroptosis in the tumor microenvironment: Perspectives for immunotherapy of SCLC
Xing Niu, Lijie Chen, Yan Li, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 273-285
Closed Access | Times Cited: 177
Verification of ferroptosis and pyroptosis and identification of PTGS2 as the hub gene in human coronary artery atherosclerosis
Yaqing Zhou, Hanxiao Zhou, Lei Hua, et al.
Free Radical Biology and Medicine (2021) Vol. 171, pp. 55-68
Closed Access | Times Cited: 175
Mitochondria-Targeting Polymer Micelle of Dichloroacetate Induced Pyroptosis to Enhance Osteosarcoma Immunotherapy
Jiakang Jin, Pengcheng Yuan, Wei Yu, et al.
ACS Nano (2022) Vol. 16, Iss. 7, pp. 10327-10340
Closed Access | Times Cited: 102
Novel strategies for cancer immunotherapy: counter-immunoediting therapy
Shaochuan Liu, Qian Sun, Xiubao Ren
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 49
Targeting the mevalonate pathway suppresses ARID1A-inactivated cancers by promoting pyroptosis
Wei Zhou, Heng Liu, Zhe Yuan, et al.
Cancer Cell (2023) Vol. 41, Iss. 4, pp. 740-756.e10
Open Access | Times Cited: 44
Smart responsive Fe/Mn nanovaccine triggers liver cancer immunotherapy via pyroptosis and pyroptosis-boosted cGAS-STING activation
Qianying Du, Ying Luo, Lian Xu, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 21
Pyroptosis: a double-edged sword in lung cancer and other respiratory diseases
Xiao Liang, Ya Qin, Dan Wu, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 16
Turning up the heat on non-immunoreactive tumors: pyroptosis influences the tumor immune microenvironment in bladder cancer
Xingyu Chen, Haotian Chen, Honghui Yao, et al.
Oncogene (2021) Vol. 40, Iss. 45, pp. 6381-6393
Closed Access | Times Cited: 72
A Dual‐Responsive STAT3 Inhibitor Nanoprodrug Combined with Oncolytic Virus Elicits Synergistic Antitumor Immune Responses by Igniting Pyroptosis
Wen Su, Wei Qiu, Shu‐Jin Li, et al.
Advanced Materials (2022) Vol. 35, Iss. 11
Closed Access | Times Cited: 69
Regulation of programmed cell death by Brd4
Jinfeng Hu, Dun Pan, Guo Li, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 12
Open Access | Times Cited: 47
Pyroptosis relates to tumor microenvironment remodeling and prognosis: A pan-cancer perspective
Muhammad Khan, Mei-Ling Ai, Kunpeng Du, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 42
Targeting Cancer Cell Ferroptosis to Reverse Immune Checkpoint Inhibitor Therapy Resistance
Jingjing Deng, Mei Zhou, Tingting Liao, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 41
Effect of regulatory cell death on the occurrence and development of head and neck squamous cell carcinoma
Yu‐Ting Xue, Xuejiao Jiang, Junrong Wang, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 28
Revealing the Mutually Enhanced Mechanism of Necroptosis and Immunotherapy Induced by Defect Engineering and Piezoelectric Effect
Yaqian Du, Jiani Yang, Fei He, et al.
Advanced Materials (2023) Vol. 36, Iss. 6
Closed Access | Times Cited: 28
CTLA-4 blockade induces tumor pyroptosis via CD8+ T cells in head and neck squamous cell carcinoma
Shuo Wang, Zhi‐Zhong Wu, Su‐Wen Zhu, et al.
Molecular Therapy (2023) Vol. 31, Iss. 7, pp. 2154-2168
Closed Access | Times Cited: 27
Targeting tumor-associated macrophages with STING agonism improves the antitumor efficacy of osimertinib in a mouse model of EGFR-mutant lung cancer
Ziying Lin, Qiwei Wang, Tao Jiang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 24
Inhibition of CDC20 potentiates anti-tumor immunity through facilitating GSDME-mediated pyroptosis in prostate cancer
Fei Wu, Minglei Wang, Tao Zhong, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 24
Biomaterials Elicit Pyroptosis Enhancing Cancer Immunotherapy
Meng‐Jie Zhang, Yuanyuan Wang, Lin‐Lin Han, et al.
Advanced Functional Materials (2023) Vol. 34, Iss. 7
Closed Access | Times Cited: 24
Immunogenic cell death in cancer immunotherapy
Minji Choi, Jisoo Shin, Chae-Eun Lee, et al.
BMB Reports (2023) Vol. 56, Iss. 5, pp. 275-286
Open Access | Times Cited: 23
Targeting STING elicits GSDMD-dependent pyroptosis and boosts anti-tumor immunity in renal cell carcinoma
Shengpan Wu, Baojun Wang, Hongzhao Li, et al.
Oncogene (2024) Vol. 43, Iss. 20, pp. 1534-1548
Closed Access | Times Cited: 9
The role of hydrogen sulfide regulation of pyroptosis in different pathological processes
Yanting Zhang, Huijie Zhao, Xiaodi Fu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 268, pp. 116254-116254
Closed Access | Times Cited: 8
Identification of a Novel Pyroptosis-Related lncRNAs Prognosis Model and Subtypes in Ovarian Cancer
Xiaofeng Xie, Xiaoqian Hu, Deng-xiang Liu, et al.
Phenomics (2025)
Closed Access | Times Cited: 1
Pyroptosis, a New Breakthrough in Cancer Treatment
Dengqiang Wu, Changhong Wei, Yujie Li, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 42
Page 1 - Next Page

Scroll to top